Impeto Medical

Impeto Medical is a commercial-stage medical device company with a focus on neuropathic diagnostics. Its flagship product, SUDOSCAN, is a patented, FDA-cleared and CE-marked device that measures electrochemical skin conductance to assess sudomotor function as a proxy for small fiber neuropathy. With over 5,000 devices sold globally and a growing body of clinical evidence, the company has established a significant presence in the neuropathy diagnostic market. Impeto is expanding its platform with Sudocloud, a remote patient monitoring solution, to enhance data management and longitudinal patient follow-up.

Patented technology measuring Electrochemical Skin Conductance (ESC) via non-invasive electrodes on hands and feet to assess sudomotor function and small fiber neuropathy.

Competes against traditional, often invasive or subjective, methods for diagnosing small fiber neuropathy such as skin punch biopsy, quantitative sensory testing, and autonomic reflex screens. Potential competition from other emerging non-invasive technologies, but SUDOSCAN has a first-mover advantage with established regulatory clearances and a large clinical publication base.